Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Keywords must be a minimum of 3 to 5 words from MESH browser.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • Where available, URLs for the references have been provided.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Pakistan Journal of Medicine and Dentistry accepts manuscripts prepared in accordance with the strict requirements mentioned by Higher Education Commission.

All material submitted for publication should be sent exclusively to the Pakistan Journal of Medicine and Dentistry(PJMD). We accept only those manuscripts or data that have not been previously published or submitted elsewhere for publication. If data is found in any other publication it will be considered a scam and is liable for disciplinary consequences by reporting to the Pakistan Medical & Dental Council and Higher Education Commission. However, re-analysis of previously published data can be accepted.

Authors can submit their manuscripts online via the journal’s online submission system at or

Manuscripts must be submitted by the corresponding author of the manuscript and should not be submitted by anyone on his behalf. A successful electronic submission of a manuscript will be followed by an acknowledgment email to the principal/corresponding author.

A duly filled-in Corresponding Author’s information Performa (CA)authors consent form (AC) and Author-Declaration-Form.pdf  is mandatory for publication. The duly signed forms must be returned to the journal’s office as soon as possible. Delay in submitting the forms will result in a delay in the processing and publication of the manuscript.

Any queries therein should be addressed directly to



The corresponding author preferably be a medical graduate/M.phil/PhD/other relevant medical fields. Moreover, PJMD allows only one author to contribute as corresponding author.

Authors must provide a final list of authors with their contact details such as workplace, telephone/cell numbers, and E-mail addresses, Persistent digital identifiers (such as ResearcherID or ORCID) or links to institutional profiles must be provided to specify the identity and affiliation of authors on the manuscript at the time of submission, ensuring the correct sequence of the names of authors.

Only six authors are allowed in a single institution / single discipline study. In a multi institution / multi-disciplinary and international collaboration research, Editorial Board shall guide on individual case basis.

Authorship credit should only be given to those who have participated appropriately in the research and also to take public responsibility for the content. Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data, drafting the article or revising it critically and final approval of the version to be published. Acquisition of funding, collection of data, or general supervision of the research group, alone does not justify authorship. All persons designated as authors should qualify for authorship & all those who qualify should be listed.


The submitting author is required to invite a minimum of two individuals with requisite domain knowledge to review the article. Prior to the forwarding of a review invitation, each author-submitted reviewer is carefully checked by PJMD editorial staff with a specific focus on relevant scientific expertise.



Every submitted paper is evaluated by assistant editor and managing editor for archival and statistical analysis if applicable. They examines and authenticates the references and check for plagiarism. The manuscript then processes for initial assessment and sent to the editors of the journal and then to external reviewers.


After the initial submission criteria, we follow double blind peer review process of manuscript screening. Peer Review may take three to four to months after the initial submission of the manuscript. The editors do not serve as peer reviewers for the journal but the editors reserve the right to edit the accepted article.


The material submitted for publication may be in the form of an Original research (Randomized controlled trial – RCT, Quasi experimental study, Case Control study, Cohort study, Observational Study with statistical support, Meta-analysis etc.), Review Article, a Case Report, Short Communication, Student’s Corner/ Knowledge Attitude and practice (KAP) study and a Letter to the Editor.

Any study five years prior to date of submission is judged by Editorial Board for its suitability as many changes take place in the subject area of the study, over the period of time. In exceptional cases, if Editorial Board is of the view that data is important, article can be reviewed accordingly.


Manuscript must be submitted in typed form on MS Word. Authors should consult the journal’s instructions to authors before submitting their manuscripts.

Font: Times New Roman

Font size: 12

Spacing: Double spacing throughout the article.

Manuscripts should contain the following sections:


A cover letter that includes the information:

  • An explanation of why your manuscript should be published in Pakistan Journal of Medicine and Dentistry.
  • Confirmation that all authors have approved the manuscript for submission.
  • Confirmation that the content of the manuscript has not been published, or submitted elsewhere and not plagiarized.
  • Sample of cover letter.


The title page should carry:

  • The title of the article (not more than 10-15 words).
  • The name of each author, with designation, name of the department(s) and institution(s) to which the work should be attributed.
  • The name and office address with email of the corresponding author.
  • Source(s) of funding in the form of grants, equipment(s), drugs, or all of these.


Authors are advised to write manuscripts in British English style, in past tense and third person indirect form of narration. Manuscripts containing language inconsistencies will not be published. Authors should seek professional assistance for correction of grammatical, scientific and typographical errors before submission of the revised version of the article for publication.




An original article should have minimum word limit of about 2000 words with two tables and two figures supported by 25-30 references. Maximum length of the original manuscript should not exceed 3000 words including title page, table and references.

Sub-headings should not be used in any section of the script except in the abstract. All randomized trials should also provide a proof of being registered at the International RCT Registry.


A structured abstract of 250 words is required for original articles. Minimize the use of abbreviations and do not cite references in the abstract. The abstract must include the following separate sections:

  • Background: The context and objective of the study
  • Method: The methods/technique used in the study
  • Results: The main findings
  • Conclusions: A brief summary and potential implications

Three to ten keywords representing the main content of the article from the Medical Subject Headings (MeSH) on NCBI website. (


This section should explain the background to the study, its aims, a summary of the latest literature and rationale of the study. The section should highlight the purpose of the article using only strictly pertinent references. It is preferable not to cite more than 10-12 references in this segment.


In this section, the sampling procedure for the research should be described (patients or laboratory animals, including controls). The age, sex and other important characteristics should be clearly defined with name of ethical review committee of your organization. The methods should be written with references, apparatus (the manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow others workers to repeat the procedure. In addition, the statistical methods used to analyze the data should also be specified.

For statistical analysis, the specific test used should be named, preferably with reference for an uncommon test. Exact p-values and 95% confidence interval (CI) limits must be mentioned. All percentages must be accompanied by actual numbers.


This section should include the findings of the study, important observations and findings must be highlighted. The data of statistical analysis can take the form of text, tables, (each table, complete with title and footnotes), and legends for illustrations and photo-graphs. Each component should begin on a new page. There should be 2-4 tables or illustrations which should be in between text.


In this section, only the new and important aspects of the study should be highlighted. Repetition and redundancy of data should be avoided. The inferences of findings and their limitations, including implications for future research should be discussed with references from the latest relevant studies.


This should state clearly the main conclusions and explain the importance and relevance of the study to the field. The conclusions should be matched with the objectives of the study.


If abbreviations are used in the text, they should be defined in the text at first use and a list of abbreviations should be provided after conclusion.


All manuscripts must contain the following sections under the heading ‘Declarations’:

If any of the sections are not relevant to your manuscript, please include the heading and write ‘Not applicable’ for that section.


Please acknowledge anyone who contributed to the article who does not meet the criteria for authorship.

For example: “I like to acknowledge hospital staff and doctors for their immense contribution”.


Any conflict of interest should be declared by all authors. This may include grants or honorarium, credits and promotions, memberships or any personal or professional relationships which may appear to influence the manuscript.

Such competing interests are not unethical but should be declared.

If there are no conflict of interests, authors should still include this heading and write “none to declare.” or“Authors declared no conflict of interest.


Manuscripts reporting studies involving human participants, human data or human tissue must:

Include a statement on ethics approval and consent, the name of the ethics committee that approved the study and the committee’s reference number if appropriate.

Studies involving animals must include a statement on ethics approval.

If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.


Any company or institution who has financially contributed to the study must be acknowledged.


Authors must state that the consent of the patient/guardian was taken prior to the writing of the manuscript if applicable.


The individual contributions of authors to the manuscript should be specified in this section.

Please use initials to refer to each author’s contribution in this section.

For example: “FC analyzed and interpreted the patient data. RH performed the histological examination, and was a major contributor in writing the manuscript”.


Vancouver reference style and more than 50-70% of the references should be from the last five years from the date of submission. A 25-30 references should be cited along with Doi.

See below a few examples of references listed in the Vancouver Style.

Journal Reference:

Thrift AP, El-Serag HB, Kanwal F. Global epidemiology and burden of HCV infection and HCV related disease. Nat Rev Gastroenterol Hepatol. 2017;14(2):122-132.

Book Reference:

Katzung BG. Non-steroidal anti-inflammatory drugs. Basic and clinical pharmacology. ed. 10th, San Francisco: McGraw Hill; 2006.

Book Chapter Reference:

Lal G, Clark OH. Thyroid, parathyroid, and adrenal. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, Eds. Schwartz’s Principles of Surgery. ed.10th, New York; Mc-Graw Hill; 2015: p.1521-1596.

URL (WebPage):

Iridogoniodysgenesis, Type 1. University of Arizona College of Medicine, Department of Ophthalmology and Vision Science. sis-type-1. (Accessed on 3/22/2016).


Citations for articles/material published exclusively online or in open access (free-to-view), must contain the accurate Web addresses (URLs) at the end of the reference(s), except those posted on an author’s Web site (unless editorially essential), e.g. ‘Reference: Available from URL’.

Echocardiographic     features    of     dilated     cardiomyopathy    [Internet].Available from: 983 [cited 27 November 2016].

Some important points to remember:

All references must be complete and accurate.

  • List all authors if the total number of authors is six or less and for more than six authors use et al. after six (the term “et al.” should be in italics).
  • Date of access should be provided for online citations.
  • Journal names should be abbreviated according to the Index Medicus/MEDLINE.
  • Punctuation should be properly applied as mentioned in the examples given above.
  • Add Doi for all the references.

The author must verify the references against the original documents before submitting the article.

  • The Editorial Board may ask authors to submit either soft or hard copies (full length) of all the articles cited in the reference part of the manuscript.


A review should have unstructured Abstract (200 words), an introduction (200 words), and Discussion (up to 2000 words), with 40 to 60 references. Also give table/flow chart /diagram for better explanation of data.

Reviews are a feature of the journal that may include, but are not limited to the following types of articles:

  • Systematic and substantial syntheses of specific research areas
  • Evaluations of progress in specified areas
  • Critical assessments with respect to issues.

The abstract should not exceed 200 words and should be unstructured. Please minimize the use of abbreviations and do not cite references in the abstract. Write about the search strategy e.g., from which search engines data is retrieved and of how many years’ data is included in the study.


Three to ten keywords representing the main content of the article from the Medical Subject Headings (MeSH) on NCBI website. (


The introduction section should explain the background to the article, its aims, a summary of a search of the existing literature and the issue under discussion.


This should contain the body of the article and may also be broken into subsections with short and informative headings.


This should state clearly the main conclusions and include an explanation of their relevance or importance to the field.


If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.


For this section see details in original article section.


Vancouver reference style and latest references (last five years) should be specified in this section. A 40-60 references should be cited along with Doi.



Case Report: Short report of cases, clinical experience, drug trials and adverse effects can be submitted. Maximum length should not exceed 1500 words, 10-15 references, one table or two illustrations. It must contain genuinely new information.

Its format should: Title, Abstract, Introduction, Case Report, Discussion and References. Short report of cases, clinical experience, drug trials and adverse effects can be submitted. Case reports should not include review of literature.


The unstructured abstract should not exceed 150 words. Please minimize the use of abbreviations and do not cite references in the abstract.


Three to ten keywords representing the main content of the article from the Medical Subject Headings (MeSH) on NCBI website. (


The Background section should explain the background to the case report or study, its aims, a summary of the existing literature.


This section should include a description of the patient’s relevant demographic details, medical history, symptoms and signs, treatment or intervention, outcomes and any other significant details.


This should emphasize present findings and the variations or similarities with other work done in the field by other workers. Detailed data should not be repeated in the discussion again. Emphasize the new and important aspects of the study and the conclusions that follow from them.


This should state clearly the main conclusions and include an explanation of their relevance or importance to the field.


If abbreviations are used in the text, they should be defined in the text at first use, and a list of abbreviations should be provided.


For this section see details in original article section.


Vancouver reference style and latest references (last five years) should be specified in this section. A minimum of 10 references should be cited along with Doi.



Meta-Analyses are a feature of the journal that may include, but are not limited to, the quantitative, scientific synthesis of research results within the scope of Pakistan journal of Medical and Dentistry.

Authors must clearly acknowledge any work upon which they are building, both published and unpublished.


The abstract of the manuscript should not exceed 300 words and must be structured into separate sections. (Non-structured abstract is also acceptable in case of a narrative review).


The context and objective of the review.


How the review was performed, including data sources, study eligibility criteria, participants and interventions; study appraisal and statistical tests used.


The main findings, including results of search and assessment of evidence base.


Brief summary and potential implications for policy/management and research.


Authors are asked to provide registration information about the meta-analysis, including a registration number.


Three to ten keywords representing the main content of the article from the Medical Subject Headings (MeSH) on NCBI website. (


The Main text should consist of following sections.


This section should be written clearly explain why a meta-analysis on this topic was needed and what it aimed to contribute to the field. The section should end with the main question(s) of the review and a brief statement of what is being reported with reference to participants, interventions, outcomes and study design.


This should include a clear description of all stages of the review process and the design of the review, the setting, the type of participants or materials involved, and the type of analysis. Describe the methods used for assessing risk of bias of individual studies, including specification of whether this was done at the study or outcome level, and how this information was used in any data synthesis. Discussions with experts and stakeholders at early stages should help identify the methodological standards for the topic of interest.

  • Data extraction strategy: what sort of data do you expect to find or have finally extracted and how you computed effect sizes and their variability.
  • Data synthesis and presentation: Report the qualitative and quantitative methods you used to synthesize and present the data, as well as elements you anticipate or have identified such as effect modifiers, type of methodologies and their current appraisal, biases etc.
  • Review statistics: The number of articles found in the search and included at each inclusion/exclusion level, along with any relevant information on the distribution of the studies found (e.g. geographical location and source of study). A flow diagram (conforming to relevant reporting guidelines e.g. PRISMA) reporting the inclusion/exclusion process should be presented.
  • Study quality assessment: A summary of what the different studies found, the confidence in the results of the different studies, what biases were present in each of the studies, and quality of the different studies needs to be included.
  • Quantitative synthesis/Meta-analysis (when possible):If effect sizes can be calculated for the included studies which measure similar outcomes then a quantitative assessment of these effect sizes should be carried out, including summary statistics of the mean effect, confidence in the mean, the range of effects and sources of heterogeneity in the effect.
  • Evidence of effectiveness: A detailed evaluation of the information on the impact of the intervention that the papers give, what evidence of an effect is there and what is the strength of the evidence including the critical appraisal of the articles. In addition, there needs to be an unbiased assessment of what level of evidence the studies provide.

Speculation within the discussion section should be limited only to suggestions for further enquiry or analysis e.g. potential reasons for heterogeneity in outcome, including the possible effect modifiers and impact of variation in the study variables such as experimental design. A section on review limitations should normally be included, including limitations due to the search strategy and bias in articles found. Gaps in the information provided by the studies should also be highlighted.


This should state clearly the main conclusions of the article and give a clear explanation of the implication for policy/management summarizing the state of the evidence base and the extent to which this informs decision making in relation to the review question and any measure of uncertainty surrounding the outcome.


If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.


For this section see details in original article section.


Vancouver reference style and latest references (last five years) should be specified in this section. A minimum of 25 references should be cited along with Doi.



Clinical Trials submitted for publication must be registered in public registry, provide registration proof and all RCTs must be based on CONSORT statement. Unregistered trials will not be published. For manuscript writing see the guidelines of original article.



Short Communications and commentary should be a non-structured abstract 150 words, having two tables or illustrations and not more than 15 references.



Students contributions of CHS research based on KAP study is also accepted. The general format of the Original Article should be followed 1000 to 1500 words of content.



Instructions of original article should be followed.



Letters to Editors should be concise and not exceed 400 words with a maximum of 5 references.


Legends to illustrations should be typed on the same sheet. Tables should be a supplement rather than duplicate information in the text; tables repeating information will be omitted.

Tables should be numbered consecutively in the order they are mentioned in the text. When Graphs, scatter grams, or histograms are submitted, the numerical data on which they are based should be supplied.


System International (S.I.) Unit measurement should be used. Imperial measurement units like inches, feet, etc. are not acceptable.


Photographs, X-rays, CT scans, MRI and photomicro-graphs should be sent in digital format with a minimum resolution of 3.2 mega pixels in JPEG/TIFF compression. Photographs must be sharply focused. Most photographs taken with a mobile phone camera do not fulfill the necessary requirements and, therefore, not acceptable for printing. The background of photographs must be neutral and preferably white.

Scanned photographs must have 300 or more dpi resolution. These figures and photographs must be cited in the text in consecutive order.


Final version of manuscript is sent to corresponding author for galley proof reading before publication to avoid any mistakes. Corrections should be conveyed clearly and informed to editor by e-mail.


The fee for Publication of a manuscript to PJMD is payable when the manuscript is accepted by the editorial team and ready for publication.

 Manuscript Publication Fee:  Rs. 8000/-

Manuscript will be processed for publication only after the receipt of publication fee received on OJS/email.

 International Publications, Editorials, and Letters to the Editor are exempted from publication charges. 

Fast-track publication

Fast Track Processing: Rs. 16000/- (Peer-Review Report in eight weeks) (Seek prior permission to avail this facility).

Note: For fast-track processing half payment  (Rs. 8000/-) will be accepted after the initial screening approval. Fast-track processing is available only in very few selected cases because of our limitations of human resources and financial constraints. It ensures peer review reports within 8 weeks. Authors are requested not to choose fast-track processing unless it is extremely essential.

Detailed steps of a Fast-Track Review Plan

  1. Submit a manuscript, and obtain a manuscript ID; after the scope, eligibility check, and initial screening by the editor, we offer a Fast-track plan.
  2. The rapid review process will begin after confirmation of the half payment.
  3. All following processes; editorial prerequisites check, double-blind review at least by two reviewers, and editorial decision will be concluded within said period.
  4. If the manuscript is accepted for publication, the next process will be the English language accuracy check and production stage.
  5. After approval of galley proof by the corresponding author, the manuscript will be published in a future issue.

The journal is funded by Ziauddin University


One printed copy will be supplied to the corresponding author. To ensure safe delivery, give a complete postal address.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.